Literature DB >> 670093

Drug sensitivity of an adriamycin-resistant mutant subline of mouse lymphoblastoma L5178Y cells.

T Nishimura, K Muto, N Tanaka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 670093     DOI: 10.7164/antibiotics.31.493

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  7 in total

Review 1.  Antitumor antibiotics discovered and studied at the Institute of Microbial Chemistry.

Authors:  T Takeuchi
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 2.  Tumour cell resistance to anthracyclines--a review.

Authors:  S Kaye; S Merry
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

3.  The mechanism and overcoming of resistance in ACNU-resistant sublines of C6 and 9L rat glioma.

Authors:  T Yoshida; K Shimizu; Y Ushio; T Hayakawa; H Mogami; Y Sakamoto
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

Review 4.  Animal models of leukemia: any closer to the real thing?

Authors:  Guerry J Cook; Timothy S Pardee
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

5.  In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL).

Authors:  P B Jensen; L Vindeløv; H Roed; E J Demant; M Sehested; T Skovsgaard; H H Hansen
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

6.  Cross-resistance to cytotoxic drugs in human glioma cell lines in culture.

Authors:  S Merry; S B Kaye; R I Freshney
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640

7.  Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.

Authors:  P R Twentyman; N E Fox; K A Wright; N M Bleehen
Journal:  Br J Cancer       Date:  1986-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.